Showing 271-280 of 9128 results for "".
Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/37182/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/48790/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.How to Approach a Contract Negotiation
https://practicaldermatology.com/series/pa-perspectives/how-approach-contract-negotiation/29072/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, provides tips on how to approach a contract negotiation, including the importance of using objective data while negotiating.How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.DERM2021: The Right Meeting For All Derm PAs/NPs
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-the-right-meeting-for-all-derm-pasnps/19964/Kristine Kucera, PA-C, MPAS, DHS says all dermatology physician assistants and nurse practitioners should be attending this year’s DERM2021 NP/PA CME Conference. She discusses the unique educational opportunities and access to top-notch presenters available at this meeting.Try New Things
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/try-new-things/19690/For the field of aesthetics to move forward, innovation is essential. Brian Biesman, MD discusses a responsible approach to trying new things in the clinical setting and stresses the need for caution at times.Close Up: Exploring New Research in Metastatic Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/close-up-exploring-new-research-in-metastatic-melanoma/19673/Adil Daud, MD discusses the promising results of a new study looking at the use of Tafinlar (dabrafenib) and Mekinist (trametinib) in BRAF-mutated advanced melanoma.Nanotechnology Advances
https://practicaldermatology.com/topics/skin-cancer-photoprotection/nanotechnology-advances/19638/It’s time to pay attention to nanotechnology and how it’s being utilized in the OTC and Rx space, says Adam Friedman, MD.Vanquish Approved for Circumferential Fat Reduction; Acquisition News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-vanquish-approved-for-circumferential-fat-reduction-acquisition-news/18884/BTL's Vanquish Cleared for Circumferential Fat Reduction of the Abdomen, Filler Injections Gain Popularity Off the Face, Protein Linked to Aggressive Melanomas, and new acquisitions at Kythera, Lumenis, XTRAC.